Quadrant Capital Group LLC Innoviva, Inc. Transaction History

Quadrant Capital Group LLC

$2.65 Billion
Q1 2025

A detailed history of Quadrant Capital Group LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 21,521 shares of INVA stock, worth $448,067. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,521

Previous 8,957 140.27%

Holding current value

$448,067

Previous $155,000 151.61%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$17.21 - $18.98 $216,226 - $238,464	12,564 Added 140.27%	21,521 $390,000
Q3 2024 Nov 12, 2024	SELL	$16.33 - $20.04 $1,045 - $1,282	-64 Reduced 0.71%	8,957 $172,000
Q2 2024 Aug 12, 2024	SELL	$14.4 - $16.4 $4,132 - $4,706	-287 Reduced 3.08%	9,021 $147,000
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $3,872 - $4,463	266 Added 2.94%	9,308 $141,000
Q4 2023 Feb 08, 2024	BUY	$12.32 - $16.27 $13,009 - $17,181	1,056 Added 13.22%	9,042 $145,000
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $2,263 - $2,541	-183 Reduced 2.24%	7,986 $103,000
Q2 2023 Aug 09, 2023	BUY	$11.39 - $13.72 $30,969 - $37,304	2,719 Added 49.89%	8,169 $103,000
Q1 2023 May 11, 2023	BUY	$10.73 - $13.6 $29,421 - $37,291	2,742 Added 101.26%	5,450 $61,000
Q4 2022 Feb 10, 2023	BUY	$11.8 - $13.78 $6,407 - $7,482	543 Added 25.08%	2,708 $35,000
Q3 2022 Nov 10, 2022	BUY	$11.61 - $15.22 $24,137 - $31,642	2,079 Added 2417.44%	2,165 $25,000
Q2 2022 Aug 09, 2022	SELL	$14.32 - $19.88 $1,489 - $2,067	-104 Reduced 54.74%	86 $1,000
Q1 2022 May 06, 2022	BUY	$15.39 - $20.25 $1,939 - $2,551	126 Added 196.88%	190 $4,000
Q3 2021 Nov 12, 2021	BUY	$13.06 - $17.24 $208 - $275	16 Added 33.33%	64 $1,000
Q2 2021 Aug 09, 2021	BUY	$11.45 - $13.96 $114 - $139	10 Added 26.32%	48 $1,000
Q1 2021 May 12, 2021	BUY	$11.06 - $12.87 $420 - $489	38 New	38 $0
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $419 - $561	-45 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$10.33 - $14.49 $175 - $246	-17 Reduced 27.42%	45 $0
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $502 - $944	62 New	62 $1,000
Q3 2019 Oct 24, 2019	SELL	$10.05 - $14.55 $19,386 - $28,066	-1,929 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$13.69 - $20.06 $26,408 - $38,695	1,929 New	1,929 $27,000

Others Institutions Holding INVA

# of Institutions

256

Shares Held

75M

Call Options Held

2.3K

Put Options Held

2.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.45B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Innoviva, Inc. Transaction History